• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Kinetic Concepts touts tissue injector acquisition

Kinetic Concepts touts tissue injector acquisition

January 28, 2014 By Arezu Sarvestani

Kinetic Concepts touts tissue injector acquisition

Kinetic Concepts sister company LifeCell this week announced the acquisition of fat-injection devices from California medtech group TauTona.

LifeCell hopes to use the deal, the details of which were not disclosed, to expand its reconstructive and cosmetic portfolio with the fat grafting technology.

Medtech incubator and investment group TauTona developed the adipose Tissue Injector as a hand-held, disposable system of transferring tissue, namely fat, from one area of the body to another. The device is battery-powered and designed to "deliver fat at an even, controlled rate without clogging," according to a company statement.

The sale is TauTona’s 2nd such exit, which the company touted as evidence of the success of its hybrid incubation-and-investment model. The company was founded in 2010 by a pair of Stanford School of Medicine surgery professors and now invests in and aids in development of new medical devices.

The aTI device is the 2nd in LifeCell’s fat grafting portfolio, which includes the Revolve fat processing system that LifeCell launched in October 2013.

"With this acquisition, we will leverage the LifeCell sales channel in the reconstructive and plastic surgery fields to commercialize this exciting new technology," KCI president & CEO Joe Woody said in prepared remarks. "We continue to be focused on innovation and acquisitions of technologies and platforms that both complement and further diversify our combined product portfolio."

LifeCell, Kinetic Concepts and Systagenix last year announced that they would join forces to form a single wound care, biologics and regenerative medicines company, led by KCI president & CEO Joe Woody. LifeCell and Kinetic Concepts merged earlier, with Systagenix joining the mix officially in the 4th quarter of 2013 after a $485 million buyout.

Kinetic Concepts last year was snapped up in a $6.1 billion leveraged buyout by an Apax Partners-led consortium that included a coupe of Canadian pension funds. The deal was one of the largest leveraged buyouts since before the global recession of 2008.

Filed Under: Cosmetic/Aesthetic, Mergers & Acquisitions, News Well Tagged With: Kinetic Concepts Inc., LifeCell Corp., Systagenix Wound Management Inc., TauTona Group

More recent news

  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure
  • NanoVibronix enters into $50M financing agreement

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy